We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$788M
AUM Growth
+$76.4M
Cap. Flow
+$93.3M
Cap. Flow %
11.84%
Top 10 Hldgs %
20.11%
Holding
191
New
20
Increased
71
Reduced
52
Closed
23

Top Buys

Rank Stock Value
1
BLFS icon
BioLife Solutions
BLFS
+$11.3M
2
WK icon
Workiva
WK
+$10.3M
3
AZTA icon
Azenta
AZTA
+$10.3M
4
ABG icon
Asbury Automotive
ABG
+$8.63M
5
AZEK
The AZEK Co
AZEK
+$7.1M

Top Sells

Rank Stock Value
1
HXL icon
Hexcel
HXL
+$7.06M
2
ENS icon
EnerSys
ENS
+$4.73M
3
OLLI icon
Ollie's Bargain Outlet
OLLI
+$4.66M
4
WTFC icon
Wintrust Financial
WTFC
+$4.35M
5
TPIC
TPI Composites
TPIC
+$4.21M

Sector Composition

Rank Sector Weight
1 Technology 20.6%
2 Financials 20.22%
3 Industrials 16.49%
4 Consumer Discretionary 11.17%
5 Healthcare 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HQY icon
176
HealthEquity
HQY
$8.75B
– –
-35,717
Closed -$2.88M
HXL icon
177
Hexcel
HXL
$7.82B
– –
-113,075
Closed -$7.06M
LW icon
178
Lamb Weston
LW
$7.19B
– –
-3,048
Closed -$246K
MDU icon
179
MDU Resources
MDU
$4.32B
– –
-27,945
Closed -$333K
PHM icon
180
Pultegroup
PHM
$25.3B
– –
-5,767
Closed -$315K
PRI icon
181
Primerica
PRI
$9.89B
– –
-11,883
Closed -$1.82M
SYF icon
182
Synchrony
SYF
$25.6B
– –
-50,551
Closed -$2.45M
TGTX icon
183
TG Therapeutics
TGTX
$7.62B
– –
-74,599
Closed -$2.89M
THG icon
184
Hanover Insurance
THG
$7.98B
– –
-9,428
Closed -$1.28M
TPIC
185
DELISTED
TPI Composites
TPIC
– –
-86,886
Closed -$4.21M
TXN icon
186
Texas Instruments
TXN
$261B
– –
-6,163
Closed -$1.19M
PGTI
187
DELISTED
PGT, Inc.
PGTI
– –
-173,607
Closed -$4.03M
TCRR
188
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-124,062
Closed -$2.04M
COUP
189
DELISTED
Coupa Software Incorporated
COUP
– –
-910
Closed -$239K
VIVO
190
DELISTED
Meridian Bioscience Inc
VIVO
– –
-137,075
Closed -$3.04M
DRNA
191
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-96,237
Closed -$3.59M
4 5 6 7
8

Similar funds

CAM
Cander Asset Management New York $557M AUM
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return

Moody Aldrich Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Moody Aldrich Partners held 191 positions worth $788M, up 11% from $712M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Moody Aldrich Partners deployed $93.3M of net new capital in Q3 2021, opening 20 new positions and adding to 71 existing holdings. Its largest new stake was BioLife Solutions: 233,787 shares worth $9.89M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Ollie's Bargain Outlet, an estimated $4.66M trimmed.

  • Moody Aldrich Partners's largest Q3 2021 buy was BioLife Solutions: 233,787 shares worth $9.89M.
  • Moody Aldrich Partners added most to Chord Energy in Q3 2021, an estimated $6.13M increase.
  • Moody Aldrich Partners's biggest Q3 2021 reduction was Ollie's Bargain Outlet, cutting an estimated $4.66M.
  • Moody Aldrich Partners fully exited Hexcel in Q3 2021, selling an estimated $7.06M.
  • Moody Aldrich Partners's ten largest holdings make up 20% of its $788M portfolio in Q3 2021.
  • Moody Aldrich Partners opened 20 new positions and closed 23 in Q3 2021.
  • Moody Aldrich Partners's portfolio value rose 11% quarter-over-quarter to $788M.

Based on Moody Aldrich Partners's 13F filing for Q3 2021, filed 29 Oct 2021.